InterWest invests an average of about $7 - 15 million over the span of their involvement with each company in their portfolio.
Business Model:
Revenue: $44.2M
Employees: 201-500
Address: 2710 Sand Hill Rd
City: Menlo Park
State: CA
Zip: 94025
Country: US
InterWest invests an average of about $7 - 15 million over the span of their involvement with each company in their portfolio. They invest in companies through the full range of venture investment stages, and investments may be staged over several rounds of financing. Although they generally begin their involvement in the early stages of a company&s;s development, they pursue attractive opportunities based on their individual merits rather than their investment stage.
Contact Phone:
+16508548585
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2009 | Achates Power | Series A | 12.1M |
1/2014 | Crowdpac | Seed Round | 2.5M |
2/2006 | SpectraLinear | Series A | 8M |
5/2016 | Obalon Therapeutics | Series E | 0 |
8/2002 | Covaro Networks | Series A | 16.7M |
9/2005 | Vendavo | Series E | 15M |
3/2010 | Advanced Micro-Fabrication Equipment | Venture Round | 5.1M |
12/2004 | Intarcia Therapeutics | Series E | 50M |
11/2007 | Carbylan Therapeutics | Series B | 20M |
5/2005 | BioMimetic Therapeutics | Series C | 11.8M |
2/2003 | Brecis Communications | Series C | 20M |
4/2011 | Eiger BioPharmaceuticals | Series A | 14.5M |
9/2006 | Quantance | Series A | 7M |
4/1999 | Intarcia Therapeutics | Series B | 12.1M |
9/2013 | Indi Molecular | Seed Round | 1.5M |
6/2007 | Tapjoy | Series A | 4.6M |
10/2005 | ReVision Optics | Series C | 12M |
7/2000 | Scale Eight | Series B | 26.5M |
4/2005 | Bivio Networks | Venture Round | 16.5M |
3/2004 | Aspreva Pharmaceuticals Corp | Series A | 57M |
4/2016 | The RealReal | Series E | 40M |
5/2007 | Solace Pharmaceuticals | Series A | 15M |
1/2008 | Pivot3 | Series C | 24M |
2/2010 | Pivot3 | Series D | 25M |
2/2015 | Pivot3 | Venture Round | 45M |
11/2007 | Platform Solutions | Series C | 37M |
10/2014 | Pivot3 | Series E | 2M |
4/2011 | INVIDI Technologies | Series D | 0 |
3/2005 | INVIDI Technologies | Series B | 20.3M |
7/2007 | CardioMind | Series C | 11M |
3/2008 | CardioMind | Venture Round | 22M |
6/2012 | Locbox | Venture Round | 5M |
12/2004 | QuatRx Pharmaceuticals | Series D | 15M |
6/2008 | OmniPV | Venture Round | 5M |
3/2010 | Advanced Micro-Fabrication Equipment | Series D | 46M |
10/1999 | Tasman Networks | Venture Round | 21M |
10/2017 | Achates Power | Series D | 0 |
3/2013 | Hangtime | Seed Round | 3.5M |
8/2009 | Pelican Imaging | Series A | 7M |
2/2012 | Satori Pharmaceuticals | Venture Round | 15M |
6/2013 | Biba | Series B | 15M |
2/2014 | Welltok | Series C | 22.1M |
10/2014 | Braze | Series B | 15M |
9/2017 | Braze | Series D | 50M |
12/2007 | Arcion Therapeutics | Series A | 8.8M |
6/2003 | QuatRx Pharmaceuticals | Series C | 14M |
10/2008 | Advanced Micro-Fabrication Equipment | Series C | 58M |
1/2006 | Staccato Communications | Series C | 18M |
12/2004 | Advanced Micro-Fabrication Equipment | Series A | 1M |
9/2005 | Standard BioTools | Series D | 0 |
3/2016 | Tizona Therapeutics | Series B | 43M |
8/2011 | Restoration Robotics | Series C | 41M |
1/2007 | Gynesonics | Series B | 16.5M |
6/2014 | Cidara Therapeutics | Series A | 32M |
1/2019 | Splice Machine | Venture Round | 0 |
1/2013 | Carbylan Therapeutics | Venture Round | 6M |
12/2003 | USGI Medical | Series B | 12M |
7/2002 | Anesiva | Series C | 50.4M |
12/2002 | Scale Eight | Series D | 4M |
2/2013 | Gynesonics | Series D | 21M |
7/2015 | Gynesonics | Venture Round | 43M |
2/2012 | SchoolFeed | Seed Round | 1.8M |
1/2006 | Amplimmune | Series A | 20M |
5/2002 | eNeura Therapeutics | Series A | 1M |
3/2008 | Gear6 | Venture Round | 10M |
10/2013 | Pivot3 | Venture Round | 0 |
12/2000 | Alfalight | Series B | 28M |
8/2015 | Mobee | Series A | 5M |
8/2015 | Wiser Solutions | Series A | 5M |
10/2009 | Integrated Diagnostics | Series A | 30M |
8/2004 | Avera Pharmaceutical | Series C | 0 |
4/1994 | Ciena | Series A | - |
5/2007 | CVRx | Series D | 65M |
7/2007 | C9 Inc. | Series A | 5M |
7/2003 | Southampton Photonics | Series B | - |
11/2016 | Cheetah Digital | Series A | 9M |
6/2007 | ARCA biopharma | Series B | 18M |
8/2007 | Nereus Pharmaceuticals | Series D | 0 |
9/2017 | Aria Systems | Series F | 0 |
8/2000 | Epocrates | Series B | 35M |
12/2018 | Aria Systems | Private Equity Round | 0 |
8/2002 | Epocrates | Series C | - |
10/2009 | Neuronetics | Series D | 0 |
8/2006 | Neuronetics | Series C | 0 |
10/2005 | Nereus Pharmaceuticals | Series D | 0 |
3/2014 | Grokker | Series A | 10M |
1/2006 | Archus Orthopedics | Series C | 35M |
6/2003 | Intarcia Therapeutics | Series D | 43M |
6/2015 | Realeve | Series D | 43.2M |
8/2006 | Bivio Networks | Venture Round | 8.5M |
8/2008 | Brand.net | Series B | 10M |
1/2005 | Ample Communications | Series D | 10.4M |
3/2001 | LongBoard | Series B | 24M |
12/2015 | Triposo | Venture Round | 3.1M |
12/2008 | Bivio Networks | Venture Round | 0 |
11/2000 | Bivio Networks | Series A | 20M |
1/2005 | Venturi Wireless | Series C | 10M |
11/2005 | LongBoard | Series D | 4M |
5/2013 | Aviate | Venture Round | 1.8M |
2/2004 | Ample Communications | Series C | 15M |
8/2003 | Myogen | Series D | 40M |
2/2017 | PMV Pharmaceuticals | Series B | 74M |
2/2009 | Exalt Communications | Series C | 0 |
10/2001 | Metro Optix | Series C | 0 |
9/2000 | Ample Communications | Series A | 17M |
12/2004 | CardioMind | Series B | 15.1M |
7/2012 | Obalon Therapeutics | Series C | 16.5M |
8/2008 | Marketo | Series B | 8M |
7/2019 | Welcome | Venture Round | 0 |
5/2009 | Lycera | Series A | 0 |
8/2002 | Varolii | Series C | 15M |
11/2016 | Grokker | Series B | 7M |
9/2008 | Right90 | Series C | 10M |
1/1995 | Corixa | Series A | 15M |
7/2007 | Right90 | Series B | 12M |
1/2014 | Welcome | Series C | 25M |
5/2013 | Nanostim | Venture Round | 9.5M |
6/2014 | Victorious | Series A | 23.2M |
6/2004 | Paracor Medical | Series C | 30.5M |
6/2007 | Paracor Medical | Series D | 44M |
1/2001 | Salmedix | Series A | - |
2/2004 | Vendavo | Series D | 6M |
2/2016 | Aria Systems | Series E | 0 |
4/2002 | Dynavax Technologies | Series D | 0 |
2/2012 | Pivot3 | Venture Round | 23M |
4/2008 | SignalDemand | Venture Round | 20M |
10/2003 | Anesiva | Series D | 20M |
3/2016 | Eiger BioPharmaceuticals | Debt Financing | - |
1/2015 | Sera Prognostics | Series B | 20M |
5/2014 | The RealReal | Series C | 20.4M |
4/2015 | The RealReal | Series D | 40M |
8/2011 | Get Satisfaction | Series B | 10M |
7/2008 | MacroGenics | Series D | 12.5M |
12/2014 | InVisage Technologies | Series F | 32.5M |
9/2013 | HireArt | Seed Round | 1.4M |
5/2010 | INVIDI Technologies | Series D | 0 |
12/2007 | INVIDI Technologies | Series C | 0 |
8/2014 | Pivot3 | Series E | 0 |
1/2016 | Benvenue Medical | Equity | 23M |
1/2008 | Follica | Series A | 5.5M |
5/2016 | Braze | Series C | 20M |
9/2005 | C9 Inc. | Series A | 0 |
10/2021 | GoCheck | Venture Round | 0 |
9/2013 | C9 Inc. | Series D | 0 |
4/2001 | Xenon Pharmaceuticals | Venture Round | 45M |
3/2007 | Advanced Micro-Fabrication Equipment | Series B | 8M |
10/2013 | Achates Power | Series C | 35.2M |
3/2016 | TESARO | Post-IPO Equity | 155M |
4/2014 | InVisage Technologies | Series E | 0 |
2/2015 | Invuity | Equity | 22.9M |
12/2014 | PMV Pharmaceuticals | Series A | 30M |
8/2014 | Splice Machine | Series B | 18M |
12/2016 | Integrated Diagnostics | Series C | 6.1M |
6/2002 | MacroGenics | Venture Round | 12.6M |
7/2014 | Gynesonics | Debt Financing | 28.4M |
10/2008 | MacroGenics | Series D | 25M |
11/2015 | Avedro | Series E | 32M |
4/2017 | Avedro | Venture Round | 0 |
3/2007 | Open-Silicon | Series D | 10M |
1/2018 | Gynesonics | Private Equity Round | 75M |
10/2008 | Avaak | Series A | 7M |
11/2013 | GAIN Fitness | Angel Round | 2.1M |
5/2010 | C9 Inc. | Series C | 8M |
6/2016 | Khoros | Series F | 50M |
5/2006 | Eledon Pharmaceuticals | Series B | 35M |
3/2010 | Avaak | Series B | 10M |
7/2006 | Gear6 | Series C | 10M |
7/2012 | Gojee | Venture Round | 2.8M |
2/2013 | Spredfast | Series C | 18M |
4/2007 | NovaCardia | Series B | 18M |
9/2007 | Sequel Pharmaceuticals | Series A | 20M |
4/2014 | Doximity | Series C | 54M |
4/2008 | NexPlanar | Series C | 0 |
12/2001 | Again Technologies | Series C | 0 |
12/2010 | Flurry | Series C | 15M |
11/2015 | Celladon | Post-IPO Equity | 39.5M |
6/2015 | Joyus | Series C | 0 |
4/1999 | Applied Science Fiction | Venture Round | 31.5M |
9/2000 | Chiaro Networks | Series C | 100M |
5/2019 | Aryaka Networks | Series F | 0 |
12/1999 | LoanCity.com | Series B | 0 |
1/2018 | Centrexion | Series D | 67M |
7/2008 | CVRx | Series E | 0 |
9/2011 | Spredfast | Series B | 12M |
8/2008 | Glaukos | Series D | 35M |
9/2011 | Khoros | Series B | 12M |
8/2007 | Restoration Robotics | Series B | 25M |
9/2005 | Nuventix | Series A | 6.5M |
11/2004 | Voyence | Venture Round | 0 |
4/2014 | Integrated Diagnostics | Series B | 31.7M |
3/2000 | GoToMyDoc | Venture Round | 25M |
4/2019 | GoCheck | Series B | 0 |
7/2009 | C9 Inc. | Series B | - |
6/2018 | Bolt | Series B | 0 |
3/2007 | Transcept Pharmaceuticals | Series D | 40M |
6/2011 | TESARO | Series B | 101M |
10/2016 | Welltok | Series E | 0 |
1/2000 | Net32 | Venture Round | 12M |
6/2012 | AppMesh | Seed Round | 900k |
11/2009 | Calypso Medical | Series E | 50M |
10/2014 | Stellar Loyalty | Series A | 5M |
3/2016 | Bigstep | Seed Round | 0 |
1/2009 | Satori Pharmaceuticals | Series A | 22M |
4/2014 | Polymorph | Seed Round | 2.2M |
8/2004 | Platform Solutions | Series B | 13.2M |
11/2011 | Sera Prognostics | Series A | 19.3M |
4/2013 | Piggybackr | Seed Round | 325k |
4/2003 | Neuronetics | Series A | 15M |
3/2005 | Neuronetics | Series B | 8.5M |
6/2011 | Empowered Careers | Series A | 15M |
8/2004 | Platform Solutions | Series A | 10.2M |
10/2005 | Radiant Medical | Venture Round | 36M |
12/2003 | Avera Pharmaceutical | Series B | 8M |
11/2002 | Again Technologies | Series D | 6.5M |
10/2000 | Elitra Pharmaceuticals | Venture Round | 0 |
2/2009 | Eiger BioPharmaceuticals | Series A | 8.3M |
12/1994 | Ciena | Series B | - |
3/2013 | Canva | Seed Round | 6.6M |
6/2011 | Virsto | Series B | 12M |
6/2000 | Broadband Gateways | Venture Round | 0 |
10/2006 | AkaRx | Series A | 2M |
7/2013 | ReVision Optics | Series E | 55M |
7/2012 | Aryaka Networks | Series C | 25M |
3/2015 | Aryaka | Series E | 16M |
5/2002 | LongBoard | Series C | 10.3M |
12/2003 | KAI Pharmaceuticals | Series A | 17M |
5/2006 | KAI Pharmaceuticals | Series B | 35M |
6/2014 | Aryaka | Series C | 10M |
1/2015 | Welltok | Series D | 0 |
2/2005 | Pivot3 | Series B | 9M |
12/2011 | GAIN Fitness | Seed Round | 650k |
8/2016 | GoCheck | Series B | 6M |
1/2006 | NovusEdge | Series B | 6.5M |
4/2004 | Staccato Communications | Series B | 20M |
9/2016 | C3 AI | Series D | 70M |
10/2005 | eNeura Therapeutics | Series B | 5.1M |
11/2008 | Staccato Communications | Venture Round | 20M |
1/2015 | Obalon Therapeutics | Series D | 0 |
8/2007 | Vizionware | Series B | 8.2M |
4/2000 | Participate Systems | Series B | 0 |
7/2013 | Swell | Series A | 5.4M |
10/2003 | Sierra Logic | Series C | 32M |
9/2002 | Sierra Logic | Series B | 12M |
2/2007 | Trius Therapeutics | Series A | 20M |
1/2011 | Tapjoy | Series C | 21M |
6/2000 | Brecis Communications | Series A | 20.5M |
11/2004 | BioMimetic Therapeutics | Series C | 25.7M |
9/2010 | Cebix | Venture Round | 16M |
10/2012 | Cebix | Series B | 0 |
10/2010 | Carwoo | Series A | 4.5M |
12/2017 | Splice Machine | Series B | 0 |
12/2006 | Ophthonix | Series D | 35.1M |
12/2012 | Labrys Biologics | Venture Round | 14.6M |
11/2012 | Applied Genetics Technologies Corporation | Series B | 0 |
1/2013 | Labrys Biologics | Series A | 31M |
3/2014 | DataRPM | Series A | 5.1M |
11/2003 | Applied Genetics Technologies Corporation | Venture Round | 27M |
5/2013 | Pelican Imaging | Series C | 20M |
6/2009 | Applied Genetics Technologies Corporation | Venture Round | 11.8M |
7/2018 | The RealReal | Series G | 115M |
7/2013 | NeuroPace | Venture Round | 18M |
1/2012 | Invuity | Venture Round | 2M |
1/2008 | PrimeraDx (Primera Biosystems) | Series B | 21M |
9/2005 | Open Silicon | Series C | 15.1M |
4/2013 | Quantance | Series D | 12M |
2/2016 | Stellar Loyalty | Series A | 4M |
11/2006 | SpectraLinear | Series B | 14M |
5/2012 | Badgeville | Series C | 25M |
3/2011 | NexPlanar | Series D | 10M |
1/2009 | SpectraLinear | Series C | 10M |
1/2001 | Brecis Communications | Series B | 0 |
2/2012 | Optimizely | Seed Round | 2M |
6/2010 | Brand.net | Series C | 14M |
11/2012 | Flurry | Series D | 0 |
3/2008 | Spiration | Series G | 18.5M |
1/2005 | NeuroPace | Venture Round | 30M |
1/2016 | Crowdpac | Series A | 6M |
9/2015 | Welcome | Series D | 42M |
1/2008 | Nuventix | Series A | 8.5M |
2/2002 | Chiaro Networks | Series D | 80M |
2/2018 | Totango | Series C | 9M |
7/2010 | ReVision Optics | Series D | 35M |
11/2016 | ReVision Optics | Venture Round | 32M |
7/2000 | Metro Optix | Series B | 63M |
4/2000 | Metro Optix | Series A | 28M |
9/2006 | Alvine Pharmaceuticals | Series A | 21.5M |
1/2010 | MicroCHIPS | Venture Round | 16.5M |
3/2015 | Aryaka | Series C | 16M |
8/2003 | Archus Orthopedics | Series B | 18M |
5/2006 | MacroGenics | Series C | 45M |
9/2001 | MacroGenics | Series A | 13.5M |
10/2009 | PrimeraDx (Primera Biosystems) | Series C | 20M |
2/2013 | Khoros | Series C | 18M |
1/2014 | Spredfast | Series D | 32.5M |
5/2007 | Lombardi Software | Series D | 8M |
5/2011 | Neuronetics | Series E | 30M |
5/2007 | QuatRx Pharmaceuticals | Series E | 0 |
1/2016 | Tizona Therapeutics | Series A | 27M |
10/2004 | MacroGenics | Series B | 30.5M |
3/2016 | Potenza Therapeutics | Venture Round | 30M |
3/2004 | Cardiac Dimensions | Series C | 15M |
6/2017 | Neuronetics | Series G | 0 |
1/2006 | Lombardi Software | Series C | 12M |
8/2011 | Bloomspot | Series B | 35M |
3/2004 | Lombardi Software | Venture Round | 0 |
4/2013 | Welltok | Series B | 18.7M |
2/2011 | Atria Systems | Series C | 27.2M |
11/2013 | Aria Systems | Series D | 0 |
3/2011 | Doximity | Series A | 10.8M |
4/2014 | Damballa | Series E | 13M |
4/2013 | Flurry | Venture Round | 255k |
12/2013 | Flurry | Series D | 12.5M |
9/2004 | Silicon Optix | Series C | 40M |
4/2006 | Cape Clear Software | Series D | 15M |
5/2007 | Cape Clear Software | Series E | 5M |
8/2001 | Myogen | Series D | 52.4M |
1/2011 | Satori Pharmaceuticals | Series B | 7M |
1/2004 | Spiration | Series E | 0 |
9/2008 | APT Pharmaceuticals | Series B | 32M |
2/2013 | Glaukos | Series F | 30M |
4/2006 | Spiration | Series F | 13.4M |
3/2009 | LensX Lasers | Series B | 22.4M |
12/1995 | Ciena | Series C | - |
1/2010 | Flurry | Series B | 7M |
9/2008 | Microfabrica | Series B | 22.5M |
12/2011 | Amaze Software, Inc | Seed Round | 1.1M |
2/2014 | Totango | Series A | 15.5M |
9/2012 | Xirrus | Series E | 23.5M |
4/2005 | T-RAM Semiconductor | Series C | 40M |
5/2015 | Realeve | Series D | 38M |
7/2013 | Concept.io Inc. | Series A | 5.4M |
7/2011 | Varolii | Series D | 8M |
11/2011 | Marketo | Series F | 50M |
10/2005 | Ophthonix | Series C | 17M |
6/2012 | Invuity | Series D | 25M |
5/2009 | Realeve | Series B | 20M |
2/2011 | Damballa | Series D | 12M |
4/2013 | Optimizely | Series A | 28M |
10/2007 | Staccato Communications | Venture Round | 17.5M |
2/2011 | InVisage Technologies | Series C | 0 |
6/2016 | Spredfast | Series F | 50M |
11/2019 | PMV Pharmaceuticals | Series C | 0 |
1/2012 | Flotype | Seed Round | 1.4M |
5/2018 | Avedro | Series F | 0 |
6/2008 | NexPlanar | Series C | 0 |
12/1999 | Vendavo | Series B | 30.5M |
1/2015 | Cuyana | Venture Round | - |
12/2016 | Restoration Robotics | Venture Round | - |
1/2014 | Khoros | Series D | 32.5M |
11/2013 | Ocera Therapeutics | Post-IPO Equity | 0 |
5/2000 | ChipData | Series A | 10M |
1/2006 | RedShift BioAnalytics | Series A | 12M |
4/2000 | Chiaro Networks | Series B | 18M |
7/2000 | RHK | Series A | - |
8/2001 | Scale Eight | Series C | 23M |
5/2003 | AccelChip | Series B | 6.7M |
7/2007 | Convey Computer | Series A | 16M |
4/2002 | Avera Pharmaceutical | Series A | 20M |
10/2012 | Nanostim | Venture Round | 10M |
9/1999 | Participate Systems | Series A | 0 |
8/2011 | Virsto | Series B | 5M |
12/2004 | ReVision Optics | Series C | 5.5M |
11/2008 | Quantance | Series B | 12M |
9/2007 | Kajeet | Series B | 36.8M |
9/2011 | Quantance | Series C | 11M |
11/2007 | Brand.net | Series A | 3M |
12/2000 | InnovICs Wireless | Series B | 7M |
10/2010 | Pelican Imaging | Series B | 10M |
7/2011 | Nuventix | Venture Round | 0 |
1/2015 | Knotch | Venture Round | - |
12/2016 | Centrexion | Series C | 47.6M |
1/2017 | Vidora | Seed Round | - |
9/2006 | NovaCardia | Series B | 48M |
7/2009 | Convey Computer | Series B | 0 |
11/2009 | Standard BioTools | Venture Round | 0 |
1/2006 | Kajeet | Series A | 27M |
6/2006 | ReVision Optics | Series C | 3M |
1/2004 | Standard BioTools | Series D | 21M |
11/2001 | Standard BioTools | Series C | 34M |
1/2007 | Standard BioTools | Series E | 0 |
8/2008 | Follica | Series B | 11M |
6/2002 | Cardiac Dimensions | Series B | 12M |
3/2013 | Osito | Seed Round | 1.1M |
7/2007 | Diatos | Series D | 12.8M |
10/2006 | Advanced Micro-Fabrication Equipment | Series B | 38M |
4/2013 | The RealReal | Series B | 14M |
1/2006 | Carbylan Therapeutics | Series A | 7.8M |
4/2010 | Marketo | Series D | 10M |
11/2010 | Marketo | Series E | 25M |
10/2006 | Marketo | Series A | 5.4M |
12/2009 | Xirrus | Series D | 20M |
3/2014 | Invuity | Series E | 36M |
12/2007 | Cardiac Dimensions | Series D | 0 |
9/2012 | Doximity | Series B | 17M |
7/2006 | USGI Medical | Series C | 21M |
2/2009 | Tapjoy | Series B | 15M |
8/2016 | Restoration Robotics | Venture Round | - |
11/2014 | Restoration Robotics | Series C | 45M |
7/2012 | Triposo | Series A | 3.5M |
9/2016 | Restoration Robotics | Venture Round | - |
12/2001 | Scale8 | Series C | 25M |
5/2014 | Apteligent | Series C | 30M |
9/2016 | Stellar Loyalty | Venture Round | - |
5/2013 | Joyus | Series B | 11.5M |
12/2011 | Carwoo | Series A | 6M |
9/2000 | Intarcia Therapeutics | Series C | 38M |
6/2012 | Drais Pharmaceuticals | Series A | 13M |
9/2013 | AppMesh | Series A | 3M |
9/2011 | Ribbon | Pre Seed Round | 120k |
1/2005 | AccelChip | Series C | 5.3M |
5/2002 | Participate Systems | Series D | 0 |
9/2016 | Totango | Series B | 8.3M |
10/2000 | IntraLase | Venture Round | 22M |
5/2001 | Anesiva | Series B | 13M |
11/2009 | CubeTree | Series B | 8M |
8/2005 | AkaRx | Series A | 6M |
6/2014 | Benvenue Medical | Series E | 40M |
4/2012 | Alt12 Apps | Seed Round | 1.3M |
2/2013 | InVisage Technologies | Series D | 0 |
6/2002 | Salmedix | Series B | 27.5M |
3/2010 | On Demand Therapeutics | Debt Financing | 300k |
5/2006 | AkaRx | Series A | 8.1M |
9/2015 | Polymorph | Series A | 12M |
8/2016 | Wiser Solutions | Venture Round | - |
6/2000 | Southampton Photonics | Series A | 0 |
2/2012 | Integrated Diagnostics | Series A | 10M |
9/2014 | OPAL | Series A | 8M |
10/2021 | GoCheck | Venture Round | 0 |
11/2019 | PMV Pharmaceuticals | Series C | 0 |
7/2019 | Welcome | Venture Round | 0 |
5/2019 | Aryaka Networks | Series F | 0 |
4/2019 | GoCheck | Series B | 0 |
1/2019 | Splice Machine | Venture Round | 0 |
12/2018 | Aria Systems | Private Equity Round | 0 |
7/2018 | The RealReal | Series G | 0 |
6/2018 | Bolt | Series B | 0 |
5/2018 | Avedro | Series F | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|